Cost-effectiveness of human papillomavirus vaccination in Jordan: A modelling study
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation (INV-005630)
- PATH
- Gateway Foundation
This publication has 18 references indexed in Scilit:
- Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic reviewVaccine, 2024
- Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling studyVaccine, 2023
- The potential cost-effectiveness of HPV vaccination among girls in MongoliaVaccine: X, 2022
- The projected cost-effectiveness and budget impact of HPV vaccine introduction in GhanaVaccine, 2022
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030Value in Health, 2021
- Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity ApproachPharmacoEconomics, 2020
- HPV vaccinations: a Middle Eastern and north African dilemmaThe Lancet Infectious Diseases, 2017
- Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in BrazilVaccine, 2015
- Cost-effectiveness of HPV vaccination in BelizeVaccine, 2015